• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一例从患有脑室腹腔分流相关性脑膜炎患者脑脊液中分离出耐利奈唑胺和万古霉素屎肠球菌的病例报告。

A Case Report on Isolation of Linezolid- and Vancomycin-resistant Enterococcus faecium Species from Cerebrospinal Fluid of a Patient Suffering from Ventriculoperitoneal Shunt-associated Meningitis.

作者信息

Irfan Seema, Qamar Salima

机构信息

Microbiology, Aga Khan University Hospital, Karachi, PAK.

出版信息

Cureus. 2019 Sep 12;11(9):e5631. doi: 10.7759/cureus.5631.

DOI:10.7759/cureus.5631
PMID:31700734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6822916/
Abstract

Vancomycin-resistant enterococci (VRE) are one of the most common nosocomial infections. Linezolid has been used to treat such infections extensively. Over time there have been reports where linezolid resistance in enterococci has been documented. This is the first report from Pakistan where linezolid- and vancomycin-resistant Enterococcus faecium was isolated from cerebrospinal fluid (CSF) sample from infected ventriculoperitoneal (VP) shunt.

摘要

耐万古霉素肠球菌（VRE）是最常见的医院感染之一。利奈唑胺已被广泛用于治疗此类感染。随着时间的推移，已有报道记录了肠球菌对利奈唑胺耐药的情况。这是巴基斯坦的首例报告，从感染的脑室腹腔（VP）分流术的脑脊液（CSF）样本中分离出耐利奈唑胺和耐万古霉素的粪肠球菌。

相似文献

1
A Case Report on Isolation of Linezolid- and Vancomycin-resistant Enterococcus faecium Species from Cerebrospinal Fluid of a Patient Suffering from Ventriculoperitoneal Shunt-associated Meningitis.一例从患有脑室腹腔分流相关性脑膜炎患者脑脊液中分离出耐利奈唑胺和万古霉素屎肠球菌的病例报告。
Cureus. 2019 Sep 12;11(9):e5631. doi: 10.7759/cureus.5631.
2
Intravenous and Intraventricular Daptomycin Plus Intravenous Linezolid Treatment of an Infant with Vancomycin-Resistant Enterococci-Induced Ventriculoperitoneal Shunt Infection.静脉及脑室内注射达托霉素联合静脉注射利奈唑胺治疗万古霉素耐药肠球菌引起的婴儿脑室腹腔分流感染
World Neurosurg. 2019 Apr;124:328-330. doi: 10.1016/j.wneu.2019.01.065. Epub 2019 Jan 24.
3
Short course of linezolid treatment for vancomycin-resistant Enterococcus faecium meningitis.利奈唑胺短程治疗耐万古霉素屎肠球菌脑膜炎
Int J Clin Pract. 2006 Jun;60(6):740-1. doi: 10.1111/j.1368-5031.2006.00706.x.
4
Treatment options for vancomycin-resistant enterococcal infections.耐万古霉素肠球菌感染的治疗选择。
Drugs. 2002;62(3):425-41. doi: 10.2165/00003495-200262030-00002.
5
Successful treatment of vancomycin-resistant enterococcus ventriculitis in a child.一名儿童耐万古霉素肠球菌性脑室炎的成功治疗
Braz J Infect Dis. 2007 Apr;11(2):297-9. doi: 10.1590/s1413-86702007000200027.
6
In vitro antimicrobial activity of linezolid tested against vancomycin-resistant enterococci isolated in Brazilian hospitals.利奈唑胺对巴西医院分离出的耐万古霉素肠球菌的体外抗菌活性。
Braz J Infect Dis. 2001 Oct;5(5):243-51. doi: 10.1590/s1413-86702001000500002. Epub 2003 Feb 21.
7
Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.万古霉素耐药屎肠球菌分离株在治疗期间对利奈唑胺的敏感性变化：1例病例报告
J Antimicrob Chemother. 2005 Oct;56(4):787-9. doi: 10.1093/jac/dki318. Epub 2005 Sep 5.
8
Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature.利奈唑胺成功治疗耐万古霉素屎肠球菌脑膜炎：病例报告及文献复习
Clin Infect Dis. 2001 Aug 15;33(4):477-82. doi: 10.1086/321896. Epub 2001 Jul 11.
9
A case of ventricular drainage infection with a rare pathogen in cerebrospinal fluid: vancomycin-resistant Enterococcus faecium.1例脑脊液中罕见病原体引起的脑室引流感染：耐万古霉素屎肠球菌。
Microb Drug Resist. 2006 Spring;12(1):59-62. doi: 10.1089/mdr.2006.12.59.
10
Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistant Enterococcus faecium.在耐万古霉素屎肠球菌暴发后，肠球菌中利奈唑胺耐药性不断出现。
Epidemiol Infect. 2008 Aug;136(8):1131-3. doi: 10.1017/S0950268807009508. Epub 2007 Sep 25.

引用本文的文献

1
Linezolid-resistant Enterococcus faecium clinical isolates from Pakistan: a genomic analysis.巴基斯坦耐利奈唑酮屎肠球菌临床分离株：基因组分析。
BMC Microbiol. 2024 Sep 14;24(1):347. doi: 10.1186/s12866-024-03491-2.
2
Vancomycin-resistant bacteremia in End-Stage Renal Disease (ESRD) and Focal Segmental Glomerulosclerosis (FSGS) patient under hemodialysis.接受血液透析的终末期肾病（ESRD）和局灶节段性肾小球硬化（FSGS）患者的耐万古霉素菌血症
Heliyon. 2024 Aug 9;10(16):e36028. doi: 10.1016/j.heliyon.2024.e36028. eCollection 2024 Aug 30.
3
Enterococci, from Harmless Bacteria to a Pathogen.肠球菌，从无害细菌到病原体
Microorganisms. 2020 Jul 25;8(8):1118. doi: 10.3390/microorganisms8081118.

本文引用的文献

1
Intraventricular Plus Intravenous Tigecycline for the Treatment of Daptomycin Nonsusceptible Vancomycin-Resistant Enterococci in an Infant with Ventriculoperitoneal Shunt Infection.脑室-静脉注射替加环素治疗脑室-腹腔分流感染合并耐万古霉素粪肠球菌的婴儿
World Neurosurg. 2019 Oct;130:470-473. doi: 10.1016/j.wneu.2019.07.045. Epub 2019 Jul 11.
2
Polyphyletic emergence of linezolid-resistant staphylococci in the United States.美国利奈唑胺耐药葡萄球菌的多系起源。
Antimicrob Agents Chemother. 2010 Feb;54(2):742-8. doi: 10.1128/AAC.00621-09. Epub 2009 Nov 23.
3
Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistant Enterococcus faecium.在耐万古霉素屎肠球菌暴发后，肠球菌中利奈唑胺耐药性不断出现。
Epidemiol Infect. 2008 Aug;136(8):1131-3. doi: 10.1017/S0950268807009508. Epub 2007 Sep 25.
4
Linezolid-resistant Enterococcus faecium and Enterococcus faecalis isolated from a septic patient: report of first isolates in Germany.从一名败血症患者中分离出的耐利奈唑胺屎肠球菌和粪肠球菌：德国首例分离株报告
Infection. 2004 Jun;32(3):182-3. doi: 10.1007/s15010-004-3009-0.
5
Linezolid-resistant enterococci: report of the first isolates in the United Kingdom.耐利奈唑胺肠球菌：英国首例分离株报告
J Antimicrob Chemother. 2002 Nov;50(5):743-6. doi: 10.1093/jac/dkf246.
6
Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis.粪肠球菌和屎肠球菌中的基因剂量与利奈唑胺耐药性
Antimicrob Agents Chemother. 2002 Oct;46(10):3334-6. doi: 10.1128/AAC.46.10.3334-3336.2002.
7
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.耐万古霉素的屎肠球菌对利奈唑胺耐药导致的感染。
Lancet. 2001 Apr 14;357(9263):1179. doi: 10.1016/S0140-6736(00)04376-2.